Lisdexamfetamine and Workplace Interview Performance in Adolescents and Young Adults Diagnosed with ADHD

Samantha Stanford

In the current study, 18 individuals between the ages of 16 and 25 diagnosed with ADHD participated in a double-blind, placebo controlled evaluation of 40 mg of lisdexamfetamine dimesylate (Vyvanse) in a laboratory setting designed to replicate a restaurant workplace and a simulated food delivery formed on a high fidelity driving simulator. This presentation will focus on the interview performance of these participants.

Zoom Link:

Leave a Reply

Your email address will not be published. Required fields are marked *